Biopharmaceutical leader Gilead Sciences, Inc. (Nasdaq: GILD) has disclosed its acquisition of 2,930,870 shares of AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, in a regulatory filing FORM 4 with the SEC. The shares were acquired at a price of $3.75.

In after-hours, $ALVR is currently trading at $3.54, up $0.26 or 7.93%, while $GILD is trading at $76.03, down $0.15 or 0.20%.

In other news, Raytheon Co., an RTX (NYSE: RTX) business, has been awarded a significant $625,000,000 indefinite-delivery/indefinite-quantity contract. 

The contract is for the production of Force Element Terminals under the Air Force Family of Advanced Beyond Line-of-Sight Terminals program. It covers equipment procurement, interim contractor support, depot activation, contractor logistics support, and necessary studies for the system. 

The Air Force Nuclear Weapons Center in Bedford, Massachusetts, is the contracting activity responsible for this contract.

$RTX is trading at $96.30, up $0.43 (0.45%) in after-hours.

Furthermore, Textron Systems Corporation, a Textron Inc. (NYSE: TXT) company, has been awarded a significant contract valued at $144,101,966. 

The contract is a hybrid cost-no-fee, cost-plus-fixed-fee contract and includes the provision of technical, engineering, scientific, and logistical services.

The contracting activity overseeing this contract is the U.S. Army Contracting Command based in Redstone Arsenal, Alabama.

In after-hours, $TXT is trading at $66.28, down $0.16 or 0.24%.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)